Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease

This phase 3 trial evaluated the safety and hemostatic efficacy of a recombinant von Willebrand factor (rVWF) for treatment of bleeds in severe von Willebrand disease (VWD). rVWF was initially administered together with recombinant factor VIII (rFVIII) and subsequently alone, as long as hemostatic f...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood
Asıl Yazarlar: Gill, Joan C., Castaman, Giancarlo, Windyga, Jerzy, Kouides, Peter, Ragni, Margaret, Leebeek, Frank W. G., Obermann-Slupetzky, Ortrun, Chapman, Miranda, Fritsch, Sandor, Pavlova, Borislava G., Presch, Isabella, Ewenstein, Bruce
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2015
Konular:
Thrombosis and Hemostasis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616237/
https://ncbi.nlm.nih.gov/pubmed/26239086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-02-629873
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller